Lataa...
Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein
Although reducing low-density lipoprotein-cholesterol (LDL-C) levels with lipid-lowering agents (statins) decreases cardiovascular disease (CVD) risk, a substantial residual risk (up to 70% of baseline) remains after treatment in most patient populations. High-density lipoprotein (HDL) is a potentia...
Tallennettuna:
| Julkaisussa: | Arch Med Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4805367/ https://ncbi.nlm.nih.gov/pubmed/26009251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.arcmed.2015.05.009 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|